107 devices · GMDN 60245
Aortic transcatheter heart valve bioprostheses are minimally invasive devices used to replace or repair a damaged aortic valve without open-heart surgery. These valves are delivered via a catheter through the blood vessels (transarterial) or chest wall (transapical) and expand within the heart to restore proper blood flow, treating conditions like aortic stenosis or regurgitation.
These devices are typically regulated as high-risk implants, often requiring pre-market approval or clearance depending on the jurisdiction. They are supplied as complete systems, including the valve, delivery catheter, and sometimes specialized tools, and are intended for use in specialized cardiac centers by trained interventional cardiologists or surgeons.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.